BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 15577178)

  • 1. [Glucocorticoid-induced osteoporosis and bone mineral densimetry].
    Tanaka I; Oshima H
    Clin Calcium; 2004 Dec; 14(12):77-82. PubMed ID: 15577178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2005 Apr; 15(4):616-24. PubMed ID: 15802774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S
    Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanana I; Oshima H
    Clin Calcium; 2006 Nov; 16(11):1851-7. PubMed ID: 17079852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Densitometry in glucocorticoid-induced osteoporosis.
    Maricic M; Gluck O
    J Clin Densitom; 2004; 7(4):359-63. PubMed ID: 15618594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Clin Calcium; 2007 Nov; 17(11):1738-44. PubMed ID: 17982195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis].
    Tanaka I
    Clin Calcium; 2014 Sep; 24(9):1371-8. PubMed ID: 25177010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-induced osteoporosis.
    Berris KK; Repp AL; Kleerekoper M
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N; Suzuki A
    Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
    Soen S
    Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
    Suzuki Y; Sato S
    Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Densitometry in glucocorticoid-induced osteoporosis.
    Chiodini I; Francucci CM; Scillitani A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):33-7. PubMed ID: 18791349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of glucocorticoid-induced osteoporosis.
    Rizzoli R; Adachi JD; Cooper C; Dere W; Devogelaer JP; Diez-Perez A; Kanis JA; Laslop A; Mitlak B; Papapoulos S; Ralston S; Reiter S; Werhya G; Reginster JY
    Calcif Tissue Int; 2012 Oct; 91(4):225-43. PubMed ID: 22878667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2014 Mar; 24(3):417-24. PubMed ID: 24576939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of glucocorticoid-induced osteoporosis in childhood].
    Tanaka H
    Clin Calcium; 2006 Nov; 16(11):1879-86. PubMed ID: 17079856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alendronate increased bone mineral density but did not reduce new fractures in glucocorticoid induced osteoporosis.
    Compston JE
    Gut; 1999 Jun; 44(6):780-1. PubMed ID: 10375295
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glucocorticoid-induced osteoporosis].
    Foltyn W; Kos-Kudła B; Marek B; Kajdaniuk D; Głogowska-Szelag J; Siemińska L; Strzelczyk J; Borowska M
    Endokrynol Pol; 2007; 58(2):170-5. PubMed ID: 17578833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.